Revenue: The sum of all revenue fields included for a company's operating activities.
HTG Molecular Diagnostics, Inc. (HTGMQ) had Revenue of $1.03M for the most recently reported fiscal quarter, ending 2023-03-31.
| Income Statement Financials | |
|
Revenue |
$1.03M |
$-5.05M |
|
$1.15M |
|
$-0.12M |
|
$6.05M |
|
$-5.01M |
|
$-0.04M |
|
$-5.05M |
|
$-5.05M |
|
$-5.05M |
|
$-5.05M |
|
$-5.05M |
|
$-5.05M |
|
$-5.01M |
|
$-4.86M |
|
2.21M |
|
2.21M |
|
$-2.28 |
|
$-2.28 |
|
| Balance Sheet Financials | |
$9.19M |
|
$0.53M |
|
$1.68M |
|
$10.87M |
|
$6.56M |
|
-- |
|
$3.83M |
|
$10.39M |
|
$0.47M |
|
$0.47M |
|
$0.47M |
|
2.21M |
|
| Cash Flow Statement Financials | |
$-4.36M |
|
$-3.54M |
|
$-1.31M |
|
$12.21M |
|
$3.00M |
|
$-9.21M |
|
$0.13M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.40 |
|
-- |
|
-- |
|
-- |
|
6.48 |
|
-11.34% |
|
-485.48% |
|
-485.48% |
|
-- |
|
-489.35% |
|
-489.56% |
|
$-4.37M |
|
-- |
|
-- |
|
-- |
|
0.10 |
|
1.76 |
|
0.91 |
|
98.67 |
|
-1064.35% |
|
-1064.34% |
|
-46.48% |
|
-1064.35% |
|
$0.21 |
|
$-1.97 |
|
$-1.97 |
|